New Results
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
Lydia J Finney, Nicholas Glanville, Hugo Farne, Julia Aniscenko, Peter Fenwick, Samuel V Kemp, Maria-Belen Trujillo-Torralbo, Maria Adelaide Calderazzo, Jadwiga A Wedzicha, Patrick Mallia, Nathan W Bartlett, Sebastian L Johnston, Aran Singanayagam
doi: https://doi.org/10.1101/2020.06.13.149039
Lydia J Finney
1National Heart and Lung Institute, Imperial College London
Nicholas Glanville
2Prokarium, London BioScience Innovation Centre, 2 Royal College Street, London NW1 0NH
Hugo Farne
1National Heart and Lung Institute, Imperial College London
Julia Aniscenko
1National Heart and Lung Institute, Imperial College London
Peter Fenwick
1National Heart and Lung Institute, Imperial College London
Samuel V Kemp
1National Heart and Lung Institute, Imperial College London
3Royal Brompton and Harefield NHS Trust
Maria-Belen Trujillo-Torralbo
1National Heart and Lung Institute, Imperial College London
Maria Adelaide Calderazzo
1National Heart and Lung Institute, Imperial College London
Jadwiga A Wedzicha
1National Heart and Lung Institute, Imperial College London
Patrick Mallia
1National Heart and Lung Institute, Imperial College London
Nathan W Bartlett
4Faculty of Health and Medicine and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle
Sebastian L Johnston
1National Heart and Lung Institute, Imperial College London
Aran Singanayagam
1National Heart and Lung Institute, Imperial College London

Article usage
Posted June 15, 2020.
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
Lydia J Finney, Nicholas Glanville, Hugo Farne, Julia Aniscenko, Peter Fenwick, Samuel V Kemp, Maria-Belen Trujillo-Torralbo, Maria Adelaide Calderazzo, Jadwiga A Wedzicha, Patrick Mallia, Nathan W Bartlett, Sebastian L Johnston, Aran Singanayagam
bioRxiv 2020.06.13.149039; doi: https://doi.org/10.1101/2020.06.13.149039
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
Lydia J Finney, Nicholas Glanville, Hugo Farne, Julia Aniscenko, Peter Fenwick, Samuel V Kemp, Maria-Belen Trujillo-Torralbo, Maria Adelaide Calderazzo, Jadwiga A Wedzicha, Patrick Mallia, Nathan W Bartlett, Sebastian L Johnston, Aran Singanayagam
bioRxiv 2020.06.13.149039; doi: https://doi.org/10.1101/2020.06.13.149039
Subject Area
Subject Areas
- Biochemistry (9556)
- Bioengineering (7071)
- Bioinformatics (24788)
- Biophysics (12575)
- Cancer Biology (9927)
- Cell Biology (14304)
- Clinical Trials (138)
- Developmental Biology (7934)
- Ecology (12084)
- Epidemiology (2067)
- Evolutionary Biology (15962)
- Genetics (10906)
- Genomics (14713)
- Immunology (9848)
- Microbiology (23592)
- Molecular Biology (9460)
- Neuroscience (50727)
- Paleontology (369)
- Pathology (1536)
- Pharmacology and Toxicology (2675)
- Physiology (4001)
- Plant Biology (8645)
- Synthetic Biology (2388)
- Systems Biology (6416)
- Zoology (1345)